A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Non-Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
Adding Nimble advances Swoop’s position as the only integrated ecosystem built to connect patients and HCPs with the right information to improve health outcomes.
At conversationHEALTH, we have access to first-party data, including physician inquiries across specialties — these are the questions HCPs ask most frequently before they prescribe.
Swoop is an NAI member & must now disclose the demographic makeup & intended condition of its custom built audience of patients & healthcare providers.
Swoop utilizes ML, AI & RWD to uncover precise, privacy-safe segments of ideal patients that are higher in audience quality & drive increased script lift
Traditional 1:1 NPI advertising cannot engage HCP influencers. Swoop uses ML & AI in conjunction with RWD to uncover & activate these brand ambassadors